Showing 1,601 - 1,620 results of 104,010 for search '(( 50 ((we decrease) OR (nn decrease)) ) OR ( 5 ((teer decrease) OR (a decrease)) ))', query time: 1.69s Refine Results
  1. 1601
  2. 1602
  3. 1603
  4. 1604
  5. 1605
  6. 1606
  7. 1607
  8. 1608

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…To mitigate the systemic adverse effects of tofacitinib, 5-ASA–PABA–MAC and 5-ASA–PABA–diamine colon-specific delivery systems were constructed, and tofacitinib azo prodrugs <b>9</b> and <b>20a–20g</b> were synthesized accordingly. …”
  9. 1609

    Impaired Functions of Macrophage from Cystic Fibrosis Patients: CD11b, TLR-5 Decrease and sCD14, Inflammatory Cytokines Increase by Karin Simonin-Le Jeune (464354)

    Published 2013
    “…Furthermore expression of CD11b and TLR-5 were sorely decreased on CF macrophages. Beside, no difference was observed for mCD14, CD16, CD64, TLR-4 and TLR1/TLR-2 expressions. …”
  10. 1610

    Decreased copper content and activity/expression of SOD1 in circulating erythrocytes from <i>ms/−</i> mice. by Małgorzata Lenartowicz (150659)

    Published 2014
    “…<p>(<b>A</b>) Decreased copper content in erythrocytes of <i>ms/−</i> mice. …”
  11. 1611
  12. 1612
  13. 1613
  14. 1614
  15. 1615

    Targeting <i>A20</i> decreases glioma stem cell survival. by Anita B. Hjelmeland (104655)

    Published 2010
    “…<p>(A) Annexin V staining demonstrates increased apoptosis with <i>A20</i> targeting in glioma stem cells isolated from a D317 glioma xenograft or a T3359 patient specimen passaged short term in immunocompromised mice. …”
  16. 1616
  17. 1617
  18. 1618
  19. 1619
  20. 1620

    Minimal underlying data set. by Machiko K. Asaka (18334223)

    Published 2024
    “…This investigation involved measurement using the Mullen Scale of Early Learning in a representative sample of Japanese infants followed up from the age of 0 to 2 years (Nishimura et al., 2016). …”